Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME

ClinicalTrials.gov ID: NCT04108156

Public ClinicalTrials.gov record NCT04108156. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 1:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active-comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic Macular Edema (Pagoda)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy, safety, and Pharmacokinetics (PK) of the PDS with ranibizumab in participants with DME when treated every 24 weeks (Q24W) compared with intravitreal (IVT) ranibizumab 0.5 milligrams (mg) every 4 weeks (Q4W). The substudy will evaluate safety of re-implanting the updated PDS with ranibizumab and the refill-exchange procedures following re-implantation in participants with DME who were previously enrolled in the main study, GR40550. Up to 100 participants from the main study will be enrolled and followed for a maximum of 72 weeks post-re-implantation in the substudy.

Study identification

NCT ID
NCT04108156
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
672 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2019 (Actual)
Primary completion
Jul 20, 2027 (Estimated)
Completion
Jul 20, 2027 (Estimated)
Last update posted
Oct 8, 2026

2019 – 2027

United States locations

U.S. sites
89
U.S. states
30
U.S. cities
82
Facility City State ZIP Site status
Barnet Dulaney Perkins Eye Center Mesa Arizona 85206 —
Retinal Consultants of Arizona;Opthalmology Phoenix Arizona 85014 —
Arizona Retina and Vitreous Consultants Phoenix Arizona 85016 —
Associated Retina Consultants Phoenix Arizona 85020 —
California Retina Consultants Bakersfield California 93309 —
Retina-Vitreous Associates Medical Group Beverly Hills California 90211 —
The Retina Partners Encino California 91436 —
Retina Consultants of Orange County;Clinical Research Fullerton California 92835 —
Jules Stein Eye Institute/ UCLA Los Angeles California 90095 —
Northern California Retina-Vitreous Associates Mountain View California 94040 —
East Bay Retina Consultants Oakland California 94609 —
Doheny Eye Institute Pasadena California 91105 —
California Eye Specialists Medical Group Pasadena California 91107 —
Retina Consultants Medical Group Sacramento California 95841 —
Zuckerberg San Francisco General Hospital and Trauma Center San Francisco California 94110 —
Orange County Retina Medical Group Santa Ana California 92705 —
California Retina Consultants;Research Department Santa Barbara California 93103 —
Eye Center of Northern Colorado Fort Collins Colorado 80528 —
Colorado Clinical Research Lakewood Colorado 80228 —
Retina Group of New England Waterford Connecticut 06385 —
Retina Group of Florida Fort Lauderdale Florida 33308 —
National Ophthalmic Research Institute Fort Myers Florida 33912 —
Retina Specialty Institute Pensacola Florida 32503 —
Fort Lauderdale Eye Institute Plantation Florida 33324 —
Retina Vitreous Associates of Florida St. Petersburg Florida 33711 —
Southern Vitreoretinal Associates;Research Tallahassee Florida 32308 —
Retina Associates of Florida;Retina Associates of Florida Tampa Florida 33609 —
Southeast Retina Center Augusta Georgia 30909 —
Georgia Retina Marietta Georgia 30060 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
Illinois Retina Associates Joliet Illinois 60435 —
University Retina Lemont Illinois 60439 —
Wolfe Eye Clinic West Des Moines Iowa 50266 —
Retina Associates Lenexa Kansas 66215 —
Retina & Vitreous Associates of Kentucky Lexington Kentucky 40509 —
Maine Eye Center Portland Maine 04605 —
The Retina Care Center Baltimore Maryland 21209 —
Johns Hopkins Hospital;Johns Hopkins Med;Wilmer Eye Inst Baltimore Maryland 21287 —
The Retina Group of Washington;Retinal Disease Chevy Chase Maryland 20815 —
Cumberland Valley Retina Consultants;Clinical Research Hagerstown Maryland 21740 —
Retina Specialist Towson Maryland 21204 —
Tufts Medical Center Boston Massachusetts 02111 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
Vitreo Retinal Associates Worcester Massachusetts 01605 —
Retina Specialists Of Michigan Grand Rapids Michigan 49546 —
Associated Retinal Consultants - Royal Oak Royal Oak Michigan 48073 —
VitreoRetinal Surgery PLLC;DBA Retina Consultants of Minnesota Minneapolis Minnesota 55435 —
Pepose Vision Institute Chesterfield Missouri 63017 —
Retina Institute St Louis Missouri 63128 —
Sierra Eye Associates Reno Nevada 89502 —
Envision Ocular, LLC Bloomfield New Jersey 07003 —
Retina Associates of New Jersey Teaneck New Jersey 07666 —
Long Island Vitreoretinal Consultants;Opthalmology Great Neck New York 11021 —
Retina Vitreous Surgeons of Central New York Liverpool New York 13088 —
New York University (NYU) New York New York 10017 —
Ophthalmic Consultants of Long Island Oceanside New York 11572 —
Asheville Eye Associates Western Carolina Retinal Associates;Clinical Research Asheville North Carolina 28803 —
Charlotte Eye Ear Nose and Throat Associates- SouthPark;Retina Charlotte North Carolina 28210 —
Duke Eye Center Durham North Carolina 27705 —
Graystone Eye;Clinical Research Hickory North Carolina 28602 —
Cincinnati Eye Institute;Retina Cincinnati Ohio 45242 —
Cleveland Clinic Cleveland Ohio 44195 —
Ohio State Havener Eye Institute;Ophthalmology Research Columbus Ohio 43212 —
Midwest Retina;Retina/Vitreous Dublin Ohio 43016 —
Retina Vitreous Center - Glen Eagles Edmond Oklahoma 73013 —
Retina Northwest;Research Department Portland Oregon 97221 —
Mid Atlantic Retina Philadelphia Pennsylvania 19107 —
Charleston Neuroscience Ladson South Carolina 29456 —
Carolina Eyecare Physicians Mt. Pleasant South Carolina 29464 —
Palmetto Retina Center West Columbia South Carolina 29169 —
Charles Retina Institution;Retina surgery Germantown Tennessee 38138 —
Tennessee Retina Nashville Tennessee 37203 —
Retina Research Institute of Texas Abilene Texas 79606 —
Texas Retina Associates Arlington Texas 76012 —
Austin Research Center for Retina Austin Texas 78705 —
Austin Retina Associates;Opthalmology Austin Texas 78705 —
Austin Clinical Research, LLC Austin Texas 78750 —
Retina & Vitreous of Texas Bellaire Texas 77401 —
Texas Retina Associates;Research Dallas Texas 75231 —
Texas Retina Associates Fort Worth Texas 76104 —
Retina Consultants of Texas Houston Texas 77401 —
Medical Center Ophthalmology Associates San Antonio Texas 78240 —
Rocky Mountain Retina Consultants Murray Utah 84107 —
Retina Associates of Utah, PLLC;Clinical Research Salt Lake City Utah 84107 —
Piedmont Eye Center Lynchburg Virginia 24502 —
Wagner Kapoor Institute;Opthalmology Norfolk Virginia 23502 —
Retina Institute of Virginia Richmond Virginia 23235 —
Pacific Northwest Retina Silverdale Washington 98383 —
Spokane Eye Clinical Research;Spokane Eye Surgery Center Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04108156, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2026 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04108156 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →